The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery

Damir Fabijanić1, Marko Banić, Dusko Kardum

  • 1University Hospital Split, Split, Croatia. damir.fabijanic@st.t-com.hr

Insights

Elevated high-sensitivity C-reactive protein (hs-CRP) levels in coronary artery disease (CAD) patients may indicate upper gastrointestinal lesions (UGILs). Endoscopy is recommended for CAD patients with high hs-CRP to assess UGILs and manage cardiovascular risk.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Biomarkers

Background:

  • High-sensitivity C-reactive protein (hs-CRP) is an independent predictor of cardiovascular events.
  • A link between upper gastrointestinal lesions (UGILs) and coronary artery disease (CAD) has been observed.
  • The study investigates the hypothesis that UGILs elevate hs-CRP in CAD patients.

Purpose of the Study:

  • To determine if upper gastrointestinal lesions (UGILs) are associated with elevated high-sensitivity C-reactive protein (hs-CRP) levels in patients with coronary artery disease (CAD).
  • To explore the correlation between the severity of UGILs and hs-CRP levels in CAD patients.
  • To assess the clinical implications of this association for cardiovascular risk management.

Main Methods:

  • 150 patients with stable coronary artery disease (CAD) were studied.
  • Data on demographics, clinical variables, and medications were collected.
  • Upper gastrointestinal lesion (UGIL) severity was assessed using the Lanza score, H. pylori status by histology, and CAD severity by the Gensini score.
  • Logistic regression analysis was used to test the correlation between hs-CRP and UGILs.

Main Results:

  • Patients with UGILs had significantly higher hs-CRP levels (8.14 mg/l) compared to those without (4.64 mg/l).
  • hs-CRP levels showed a positive correlation with UGIL severity (r=0.434, P<0.0001).
  • This correlation remained significant after adjusting for coronary risk factors, medications, CAD severity, and H. pylori status.

Conclusions:

  • Elevated hs-CRP levels in CAD patients may serve as a predictor for underlying UGILs.
  • Endoscopic evaluation is recommended for CAD patients with elevated hs-CRP, even in the absence of dyspeptic symptoms.
  • UGILs, by increasing hs-CRP levels, might contribute to increased cardiovascular risk in these patients.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...